Bristol-Myers Squibb Co (NYSE:BMY)
| 63.53 Delayed Data As of 4:00pm ET |  -1.05 / -1.63%Today’s Change | 53.22 Today|||52-Week Range 69.75 | +1.89% Year-to-Date |
Latest BMY News | Press Releases
Today’s Trading
| Previous close | 64.58 |
| Today’s open | 64.77 |
| Day’s range | 63.29 - 64.87 |
| Volume | 13,271,069 |
| Average volume (3 months) | 12,643,413 |
| Market cap | $144.1B |
Data as of 4:00pm ET, 01/21/2022
Growth & Valuation
| Earnings growth (last year) | -297.94% |
| Earnings growth (this year) | +16.35% |
| Earnings growth (next 5 years) | +7.70% |
| Revenue growth (last year) | +62.62% |
| P/E ratio | NM |
| Price/Sales | 3.29 |
| Price/Book | 3.85 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SNYSanofi | -0.84 | -1.61% |
| NVONovo Nordisk | -0.14 | -0.15% |
| GSKGlaxoSmithKline | +0.22 | +0.49% |
| AZNAstraZeneca | -1.10 | -1.83% |
Data as of 4:00pm ET, 01/21/2022
Financials
| Next reporting date | February 4, 2022 |
| EPS forecast (this quarter) | $1.81 |
| Annual revenue (last year) | $42.5B |
| Annual profit (last year) | -$9.0B |
| Net profit margin | -21.20% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
